Search - tctmd.com

Displaying 121 - 140 of 306

Sort: Relevancy | Date

Presentation TCT 2024

Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights Into the EuroTR Registry

Presenter: Lukas Stolz

October 27, 2024

News Conference News EACTS 2024

TAVI Explant Complications a ‘Big Issue’ as Procedure Numbers Climb

Yael L. Maxwell

October 21, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Daily News

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Caitlin E. Cox

September 12, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Conference News ESC 2024

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

Todd Neale

August 31, 2024

Presentation ESC 2024

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Presenter: Erwan Donal

August 31, 2024

News Daily News

Going Contrast Free in TAVI Is Safe for CKD Patients

Caitlin E. Cox

August 20, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Features

Valvular Heart Disease Has a Diversity Problem

Yael L. Maxwell

July 12, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2024

Shelley Wood

July 02, 2024

News Daily News

Undiagnosed Valvular Heart Disease Prevalent in Older Adults

Yael L. Maxwell

June 27, 2024

News Conference News NY Valves 2024

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

Todd Neale

June 07, 2024

News Conference News NY Valves 2024

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Michael O'Riordan

June 07, 2024

Presentation NY Valves 2024

Anatomy for Tricuspid Interventions: "Live" from the OR

Presenter: Isaac George

June 07, 2024

Presentation NY Valves 2024

What’s Next? Managing the Disease and Advanced Training

Presenter: Charles J. Davidson

June 07, 2024

Presentation NY Valves 2024

Why We Need a "Toolbox" Approach for the Tricuspid Valve

Presenter: Georg Nickenig

June 07, 2024

Presentation NY Valves 2024

Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications?

Presenter: Brian K. Whisenant

June 07, 2024

Advertisement

Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights Into the EuroTR Registry

TAVI Explant Complications a ‘Big Issue’ as Procedure Numbers Climb

What’s Going to Be Big at TCT 2024?

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

TCTMD’s Top 10 Most Popular Stories for August 2024

Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Going Contrast Free in TAVI Is Safe for CKD Patients

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

August 2024 Dispatch for the CV Team

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Valvular Heart Disease Has a Diversity Problem

TCTMD’s Top 10 Most Popular Stories for June 2024

Undiagnosed Valvular Heart Disease Prevalent in Older Adults

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Anatomy for Tricuspid Interventions: "Live" from the OR

What’s Next? Managing the Disease and Advanced Training

Why We Need a "Toolbox" Approach for the Tricuspid Valve

Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content